BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12622416)

  • 1. TGFbeta-regulated transcriptional mechanisms in cancer.
    Ellenrieder V; Buck A; Gress TM
    Int J Gastrointest Cancer; 2002; 31(1-3):61-9. PubMed ID: 12622416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.
    Allen CE; Du J; Jiang B; Huang Q; Yakovich AJ; Barnard JA
    Neoplasia; 2008 Oct; 10(10):1073-82. PubMed ID: 18813357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
    Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
    J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TGFbeta signaling in skin carcinogenesis.
    Wang XJ
    Microsc Res Tech; 2001 Feb; 52(4):420-9. PubMed ID: 11170301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
    Bachman KE; Park BH
    Curr Opin Oncol; 2005 Jan; 17(1):49-54. PubMed ID: 15608513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of epithelial-mesenchymal transition by transforming growth factor β.
    Moustakas A; Heldin CH
    Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of EMT by TGFβ in cancer.
    Heldin CH; Vanlandewijck M; Moustakas A
    FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade.
    Mullenders J; Fabius AW; van Dongen MM; Kuiken HJ; Beijersbergen RL; Bernards R
    Mol Cancer Res; 2010 Apr; 8(4):592-603. PubMed ID: 20332216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis.
    Piek E; Roberts AB
    Adv Cancer Res; 2001; 83():1-54. PubMed ID: 11665716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-suppressive and promoting function of transforming growth factor beta.
    Sun L
    Front Biosci; 2004 May; 9():1925-35. PubMed ID: 14977598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transforming growth factor beta in breast carcinogenesis.
    Benson JR
    Lancet Oncol; 2004 Apr; 5(4):229-39. PubMed ID: 15050954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
    de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
    Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
    Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
    Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer.
    Ellenrieder V
    Anticancer Res; 2008; 28(3A):1531-9. PubMed ID: 18630508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFΒ-induced transcription in cancer.
    Cantelli G; Crosas-Molist E; Georgouli M; Sanz-Moreno V
    Semin Cancer Biol; 2017 Feb; 42():60-69. PubMed ID: 27586372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
    Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
    BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.